Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18007 | 509 | 40.9 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ALCAM | Author keyword | 64 | 72% | 10% | 50 |
2 | CD166 | Author keyword | 19 | 52% | 5% | 26 |
3 | CD6 | Author keyword | 17 | 59% | 4% | 19 |
4 | CD72 | Author keyword | 9 | 43% | 3% | 17 |
5 | ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE | Author keyword | 9 | 64% | 2% | 9 |
6 | NEUROLIN | Author keyword | 6 | 71% | 1% | 5 |
7 | APOPTOSIS INHIBITOR OF MACROPHAGE AIM | Author keyword | 6 | 100% | 1% | 4 |
8 | ALCAM CD166 | Author keyword | 4 | 75% | 1% | 3 |
9 | MOL BIOMED PATHOGENESIS | Address | 4 | 36% | 2% | 8 |
10 | CD5 | Author keyword | 3 | 10% | 6% | 32 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALCAM | 64 | 72% | 10% | 50 | Search ALCAM | Search ALCAM |
2 | CD166 | 19 | 52% | 5% | 26 | Search CD166 | Search CD166 |
3 | CD6 | 17 | 59% | 4% | 19 | Search CD6 | Search CD6 |
4 | CD72 | 9 | 43% | 3% | 17 | Search CD72 | Search CD72 |
5 | ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE | 9 | 64% | 2% | 9 | Search ACTIVATED+LEUKOCYTE+CELL+ADHESION+MOLECULE | Search ACTIVATED+LEUKOCYTE+CELL+ADHESION+MOLECULE |
6 | NEUROLIN | 6 | 71% | 1% | 5 | Search NEUROLIN | Search NEUROLIN |
7 | APOPTOSIS INHIBITOR OF MACROPHAGE AIM | 6 | 100% | 1% | 4 | Search APOPTOSIS+INHIBITOR+OF+MACROPHAGE+AIM | Search APOPTOSIS+INHIBITOR+OF+MACROPHAGE+AIM |
8 | ALCAM CD166 | 4 | 75% | 1% | 3 | Search ALCAM+CD166 | Search ALCAM+CD166 |
9 | CD5 | 3 | 10% | 6% | 32 | Search CD5 | Search CD5 |
10 | CD5L | 3 | 100% | 1% | 3 | Search CD5L | Search CD5L |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALCAM | 103 | 91% | 8% | 42 |
2 | ALCAM CD166 | 76 | 81% | 9% | 46 |
3 | CD6 LIGAND | 44 | 100% | 3% | 16 |
4 | MONOCLONAL ANTI LYB 2 ANTIBODY | 38 | 93% | 3% | 14 |
5 | ANTI CD6 MONOCLONAL ANTIBODY | 38 | 86% | 4% | 19 |
6 | DM GRASP | 28 | 62% | 6% | 29 |
7 | CELL BINDING CHARACTERISTICS | 26 | 87% | 3% | 13 |
8 | SRCR DOMAIN | 19 | 80% | 2% | 12 |
9 | HUMAN SP ALPHA | 15 | 88% | 1% | 7 |
10 | CD6 | 13 | 62% | 3% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Activated leukocyte cell adhesion molecule: a new paradox in cancer | 2008 | 64 | 47 | 81% |
CD6-ligand interactions: a paradigm for SRCR domain function? | 1997 | 102 | 39 | 64% |
The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease | 2011 | 15 | 54 | 44% |
The scavenger receptor cysteine-rich (SRCR) domain: An ancient and highly conserved protein module of the innate immune system | 2004 | 123 | 245 | 30% |
Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator | 2004 | 52 | 37 | 51% |
Cell surface receptors and their ligands: In vitro analysis of CD6-CD166 interactions | 2000 | 48 | 43 | 53% |
The Conserved Scavenger Receptor Cysteine-Rich Superfamily in Therapy and Diagnosis | 2011 | 31 | 419 | 18% |
CD72, a negative regulator of B-cell responsiveness | 2000 | 32 | 59 | 47% |
T-cell modulatory properties of CD5 and its role in antitumor immune responses | 2013 | 0 | 66 | 50% |
Activated leukocyte cell adhesion molecule (ALCAM/CD166): Signaling at the divide of melanoma cell clustering and cell migration? | 2005 | 59 | 85 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL BIOMED PATHOGENESIS | 4 | 36% | 1.6% | 8 |
2 | GRP CELL ACTIVAT GENE EXP S | 2 | 40% | 0.8% | 4 |
3 | INVEST BIOMED AUGUST PI SUNYER IDIBABS | 1 | 100% | 0.4% | 2 |
4 | MOL BIOMED PATHOGENESISBUNKYO KU | 1 | 50% | 0.4% | 2 |
5 | RAINBOW BABIES CHILDRENS HOSP 504 | 1 | 100% | 0.4% | 2 |
6 | BIOL CELLULAR IMMUNOL NEUROCIENCIES | 1 | 11% | 1.6% | 8 |
7 | NUCL RECEPTOR GRP | 1 | 33% | 0.4% | 2 |
8 | ASSOC ABO | 1 | 50% | 0.2% | 1 |
9 | BOWRING LADY CURZON HOSP | 1 | 50% | 0.2% | 1 |
10 | CNRS GENET PHYSIOL DEV | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000244881 | DMBT1//SALIVARY AGGLUTININ//GP 340 |
2 | 0.0000211482 | B 1 CELLS//B1 CELL//CD5 B LYMPHOCYTES |
3 | 0.0000162349 | GICERIN//CD146//NEURITE OUTGROWTH FACTOR |
4 | 0.0000105102 | SECRETOME//90K MAC 2BP//90K |
5 | 0.0000104913 | T11TS//CD2//CD58 |
6 | 0.0000075800 | L1 CAM//X LINKED HYDROCEPHALUS//MASA SYNDROME |
7 | 0.0000069197 | SCAVENGER RECEPTOR//FRACTIONATED H 3HEPARIN//CLASS A SCAVENGER RECEPTOR |
8 | 0.0000065290 | SIGLEC//SIGLECS//SIGLEC 8 |
9 | 0.0000053858 | HAPTOGLOBIN//HAPTOGLOBIN POLYMORPHISM//HAPTOGLOBIN PHENOTYPES |
10 | 0.0000053592 | MED HOWARD HUGHES MED PATHOL//CD8 BETA//CD8 IMMUNODEFICIENCY |